Walker carcinosarcoma 256 in study of anticancer agents. II. Results.
D000085:Acetates / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001389:Azirines / Q000627:therapeutic use*; D001554:Benzene / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D002087:Butyrates / Q000627:therapeutic use; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D005998:Glycine / Q000627:therapeutic use; D008353:Mannitol / Q000627:therapeutic use; D008466:Mechlorethamine / Q000627:therapeutic use*; D008558:Melphalan / Q000627:therapeutic use*; D009536:Niacinamide / Q000627:therapeutic use; D010087:Oxides / Q000627:therapeutic use; D010795:Phthalic Acids / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D051381:Rats; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*; D014050:Toluene / Q000627:therapeutic use; D014992:Xylenes / Q000627:therapeutic use
D000085:Acetates; D000970:Antineoplastic Agents; D001389:Azirines; D001565:Benzoates; D002087:Butyrates; D010087:Oxides; D010795:Phthalic Acids; D011725:Pyridines; D013438:Sulfhydryl Compounds; D014992:Xylenes; D009536:Niacinamide; D014050:Toluene; D008353:Mannitol; D008466:Mechlorethamine; D001554:Benzene; D008558:Melphalan; D005998:Glycine